Please login to the form below

Not currently logged in
Email:
Password:

EBE

This page shows the latest EBE news and features for those working in and with pharma, biotech and healthcare.

Industry welcomes European diagnostics regulations

Industry welcomes European diagnostics regulations

scandal. The European Biopharmaceutical Enterprises (EBE) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) voiced qualified support for the new IVD regulations. ... Barbara Freischem, executive director of EBE, commented:

Latest news

  • EMA on track with biosimilars guidance says industry EMA on track with biosimilars guidance says industry

    Trade organisations the European Biopharmaceutical Enterprises (EBE) and EuropaBio believe the planned revisions "offer important developments to further strengthen the biosimilars pathway in Europe", according to Eugene Corretge, strategic unit

  • Orphan drug legislation hailed as success

    Legislation governing Orphan Medicinal Products in Europe has had a positive impact, according to a joint EBE and EuropaBio task force. ... EBE (European Biopharmaceutical Enterprises) and EuropaBio's Joint Rare Diseases and Orphan Medicinal Products

  • What is EFPIA...

    EFPIA has two specialist groups to address specific issues. The European Vaccine Manufacturers (EVM) covers vaccine topics, while European Biotechnology Enterprises (EBE) deals with the needs of biopharmaceutical sector companies.

  • The mothership

    Therefore please make your contributions to your European Trade Association; be it EVM for vaccine manufacturers, Eucomed for medical device manufacturers, EBE for upcoming biopharmaceutical companies, or the mothership itself, EFPIA,

  • A model approach A model approach

    The European Biopharmaceutical Enterprises (EBE) has requested that the EC and the EMEA issue guidance and clarify the concepts of 'similarity', 'interchangeability' and 'substitution'. ... The EBE considers this to be crucial for industry and healthcare

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest appointments

  • Eduardo Bravo becomes head of EBE Eduardo Bravo becomes head of EBE

    TiGenix CEO appointed president of the EBE’s board of directors. The European Biopharmaceutical Enterprises (EBE) has appointed Eduardo Bravo as president of its board of directors for the 2016-2018 ... 2011. Barbara Freischem, EBE's executive director,

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics